FDA Inspection
SEAGEN INC.SEAGEN INC. – FDA Inspection, May 13, 2025
Record Details
This FDA Inspection record concerns SEAGEN INC., with an inspection on May 13, 2025, issued by the Seattle District Office, covering human drugs.
View Company Profile
ID · 33d5bc76-b106-486b-aa5a-2ab3314b6690
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1272265
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.25(a)Training , Education , Experience overall
Full citation text and observation details available on the Dashboard.
Other FDA inspections of SEAGEN INC.
10| Date | Classification | Office | Project area |
|---|---|---|---|
| November 1, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 2, 2024 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 24, 2020 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 4, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| January 5, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for SEAGEN INC.
- FDA Inspection 1253880 - 2024-11-01
- FDA Inspection 1236983 - 2024-05-02
- FDA Inspection 1119141 - 2020-01-24
- FDA Inspection 1107250 - 2019-10-04
- FDA Inspection 1040735 - 2018-01-05
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.